A History of Health Economics and Healthcare Delivery Research at the National Cancer Institute. Issue 59 (5th July 2022)

• Record Type: Journal Article
• Authors: Doria-Rose, V Paul; Breen, Nancy; Brown, Martin L; Feuer, Eric J; Geiger, Ann M; Kessler, Larry; Lipscomb, Joseph; Warren, Joan L; Yabroff, K Robin
• Is Part Of: Journal of the National Cancer Institute. Volume 2022:Issue 59(2022)
• Page Start: 21
• Page End: 27
• Publication Date: 2022-07-05
• Subjects: Cancer -- Periodicals; Cancer -- Congresses; 616.994
• DOI: 10.1093/jncimonographs/lgac003
• Languages: English
• ISSNs: 1052-6773

Abstract

Abstract: With increased attention to the financing and structure of healthcare, dramatic increases in the cost of diagnosing and treating cancer, and corresponding disparities in access, the study of healthcare economics and delivery has become increasingly important. The Healthcare Delivery Research Program (HDRP) in the Division of Cancer Control and Population Sciences at the National Cancer Institute (NCI) was formed in 2015 to provide a hub for cancer-related healthcare delivery and economics research. However, the roots of this program trace back much farther, at least to the formation of the NCI Division of Cancer Prevention and Control in 1983. The creation of a division focused on understanding and explaining trends in cancer morbidity and mortality was instrumental in setting the direction of cancer-related healthcare delivery and health economics research over the subsequent decades. In this commentary, we provide a brief history of health economics and healthcare delivery research at NCI, describing the organizational structure and highlighting key initiatives developed by the division, and also briefly discuss future directions. HDRP and its predecessors have supported the growth and evolution of these fields through the funding of grants and contracts; the development of data, tools, and other research resources; and thought leadership including stimulation of research on previously understudied topics. As the availability of new data, methods, and computing capacity to evaluate cancer-related healthcare delivery and economics expand, HDRP aims to continue to support this growth and evolution.